Regulation of EGF-receptor expression by EGF and TGFα in epidermoid cancer cells is cell type-specific

International Journal of Biochemistry and Cell Biology

Volumn 30, Issue 11, 1998, Pages 1265-1278

  McCulloch, Ross K ^a   Walker, Caroline E ^a   Chakera, Aron ^a   Jazayeri, Jalal ^a   Leedman, Peter J ^a  

^a ROYAL PERTH HOSPITAL   (Australia)

Author keywords

EGF; EGF receptor; Epidermoid cancer; mRNA turnover; RNA binding protein; TGF

Indexed keywords

CYTOPLASM PROTEIN; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; RNA BINDING PROTEIN; TRANSFORMING GROWTH FACTOR ALPHA;

ARTICLE; CELL SPECIFICITY; CELL STRAIN KB; CONTROLLED STUDY; HALF LIFE TIME; HUMAN; HUMAN CELL; PROTEIN RNA BINDING; SQUAMOUS CELL CARCINOMA;

3' UNTRANSLATED REGIONS; CARCINOMA, SQUAMOUS CELL; CYCLOHEXIMIDE; EPIDERMAL GROWTH FACTOR; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RNA, MESSENGER; TRANSCRIPTION, GENETIC; TRANSFORMING GROWTH FACTOR ALPHA; TUMOR CELLS, CULTURED;

EID: 0032211828     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1357-2725(98)00056-9     Document Type: Article

References (55)

1. [1] T. Hunter, J.A. Cooper, Epidermal growth factor induces rapid tyrosine phosphorylation of proteins in A431 human tumour cells, Cell 24 (1981) 741-744.
2. [2] S. Cohen, H. Ushiro, C. Stoscheck, M. Chinkers, A native 170,000 EGF-receptor kinase from shed plasma membrane vesicles, J. Biol. Chem. 257 (1982) 1523-1539.
3. [3] G. Carpenter, S. Cohen, Epidermal growth factor, J. Biol. Chem. 265 (1990) 7709-7712.
4. [4] W.A. Dunn, A.L. Hubbard, Receptor mediated endocylosis of EGF by hepatocytes in perfused rat liver, ligand and receptor dynamics, J. Cell Biol. 98 (1984) 2148-2159.
5. [5] A. Ullrich, J. Schlessinger, Signal transduction by receptors with tyrosine kinase activity, Cell 61 (1990) 205-210.
6. [6] J. Downward, Y. Yarden, E. Mayes, G. Scarce, N. Totty, P. Stockwell, A. Ullrich, J. Schlessinger, M.D. Waterfield, Close similarity of epidermal growth factor receptor and v-erb B oncogene protein sequence, Nature 307 (1984) 521-527.
7. [7] P.P. DiFiore, J.H. Pierce, T.P. Fleming, R. Hazan, A. Ullrich, C.R. King, J. Schlessinger, S.A. Aaronson, Overexpression of the human EGF receptor confers an EGF-dependent transformed phenotype to NIH3T3 cells, Cell 51 (1987) 1063-1070.
8. [8] T.J. Velu, L. Beguinot, W.C. Vass, M.C. Willingham, G.T. Merlino, I. Pastan, D.R. Lowry, Epidermal growth factor-dependent transformation by a human EGF receptor proto-oncogene, Science 238 (1987) 1408-1410.
9. [9] C.M. Stoschek, L.E. King, Role of epidermal growth factor in carcinogenesis, Cancer Res. 46 (1986) 1030-1037.
10. [10] S.L. Fitzpatrick, M.P. LaChance, G.S. Schultz, Characterization of epidermal growth factor receptor and action on human breast cancer cells in culture, Cancer Res. 44 (1984) 3442-3447.
11. [11] C.R. Lin, W.S. Chen, W. Kruiger, W. Stolarsky, I.M. Verma, G.N. Gill, M.D. Rosenfeld, Expression cloning of the human EGF receptor complimentary DNA: Gene amplification and three related mRNA products in A431 cells. Science 224 (1984) 843-848.
12. [12] T.A. Libermann, N. Razon, A.D. Bartal, Y. Yarden, J. Schlessinger, H. Soreq, Expression of epidermal growth factor receptors in human brain tumors, Cancer Res. 44 (1984) 753-760.
13. [13] G.T. Merlino, Y.-H. Xu, S. Ishii, A.J.L. Clark. K. Semba, K. Toyoshima, T. Yamamoto, I. Pastan, Amplification and enhanced expression of the epidermal growth factor receptor gene in A431 human carcinoma cells. Science 224 (1984) 417-419.
14. [14] Y.-H. Xu, S. Ishfi, A.J.L. Clark, M. Sullivan, R.K. Wilson, D.P. Ma. B.A. Roe, G.T. Merlino, I. Pastan, Human epidermal growth factor receptor cDNA is homologous to a variety of RNAs overproduced in A431 carcinoma cells. Nature 309 (1984) 806-810.
15. [15] J. Filmus, M.N. Pollak, R. Cailleau, R.N. Buick, MDA-468, a human breast cancer cell line with a high number of epidermal growth factor (EGF) receptors, has an amplified EGF receptor gene and is growth inhibited by EGF, Biochem. Biophys. Res. Commun. 128 (1985) 898-905.
16. [16] C.R. King, M.H. Kraus, L.T. Williams. G.T. Merlino, I. Pastan, A. Aaronson, Human tumor cell lines with EGF receptor gene amplification in the absence of aberrant sized mRNAs, Nucleic Acids Res. 13 (1985) 8477-8486.
17. [17] T.A. Libermann, H.R. Nusbaum, N. Razon, R. Kris, L. Lax, H. Soreq, N. Whittle, M.D. Waterfield, A. Ullrich, J. Schlessinger, Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumours of glial origin, Nature 313 (1985) 144-147.
18. [18] A. Ullrich, L. Coussens, J.S. Hayflick, T.J. Dull, A. Gray, A.W. Tam, J. Lee, Y. Yarden, T.A. Libermann, J. Schlessinger, J. Downward, E.L.V. Mayes, N. Whittle, M.D. Waterfield, P.H. Seeburg, Human EGF receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells. Nature 309 (1985) 418-425.
19. [19] T. Yamamoto, N. Kamata, H. Kawana, S. Shimuzu, T. Kuroki, K. Toyoshima, K. Rikimaru, N. Nomura, R. Ishizaki, L. Pastan, S. Gamou, N. Shimizu, High incidence of amplification of the epidermal growth factor gene in human squamous carcinoma cell lines, Cancer Res. 46 (1986) 414-416.
20. [20] F. Hendler, A. Shum, C. Richards, D. Cassels, B. Gusterson, B. Ozanne, Evidence for increased epidermal growth factor receptors in epidermoid malignancies. Cancer Cells 1 (1984) 41-50.
21. [21] P. Davies, C. Eaton, Binding of epidermal growth factor by human normal, hypertrophic and carcinomatous prostate, Prostate 14 (1989) 123-132.
22. [22] G.L. Morris. J.G. Dodd, Epidermal growth factor receptor mRNA levels in human prostate tumors and cell lines, J. Urol. 143 (1990) 1272-1274.
23. [23] J.G.M. Klijn, P.M.J.J. Berns, P.I.M. Schmitz, J.A. Foekens, The clinical significance of epidermal growth factor receptor (EGFR) in human breast cancer: A review on 5332 patients. Endocrine Rev. 13 (1992) 13-17.
24. [24] C. Jhappan, C. Stahle, R.N. Harkins, N. Fausto, G.H. Smith, G.T. Merlino, TGFα overexpression in transgenic mice induces liver neoplasia and abnormal development of the mammary gland and pancreas, Cell 61 (1990) 1137-1146.
25. [25] Y. Matsui, S.A. Halter, J.T. Holt, B.L. Hogan, R.J. CofTey, Development of mammary hyperplasia and neoplasia in MMTV-TGFα transgenic mice, Cell 61 (1990) 1147-1155.
26. [26] Y. Imai, C.K.H. Leung, H.G. Friesen, R.P. Shiu, Epidermal growth factor receptors and effect of epidermal growth factor on growth of human breast cancer cells in long term tissue culture. Cancer Res. 42 (1982) 4394-4398.
27. [27] A.B. Schreiber, M.E. Winkler, R, Derynck, Transforming growth factor-α: A more potent angiogenic mediator than epidermal growth factor. Science 232 (1986) 1250-1253.
28. [28] D. Derynck, Transforming growth factor α, Cell 54 (1988) 593-595.
29. [29] A.W. Burgess, Epidermal growth factor and transforming growth factor α, Br. Med. Bull. 45 (1989) 401-424.
30. [30] J.P. Tam, Physiological effects of transforming growth factor in the newborn mouse, Science 229 (1985) 673-675.
31. [31] S.W. Peltz, Regulation of mRNA turnover in eukaryotes, Crit. Rev. Eukaryotic Gene Expres. 1 (1991) 99-126.
32. [32] G. Shaw, R. Kamen, A conserved AU sequence from the 3′-untranslated region of GM-CSF mRNA mediates selective mRNA degradation, Cell 46 (1986) 659-668.
33. [33] M.E. Greenberg and J.G. Belasco, Control of the decay of labile protoncogene and cytokine mRNAs, in: J.G. Belasco and G. Brawerman (Eds.), Control of mRNA stability, Academic Press, San Diego, California, 1993, pp. 199-218.
34. [34] M. Akashi, G. Shaw, M. Gross, M. Saito, H.P. Koeffler, Role of AUUUA sequences in stabilization of granulocyte-macrophage colonystimulating factor RNA in stimulated cells, Blood 78 (1991) 2005-2012.
35. [35] A.M. Zubiaga, J.G. Belasco, M.E. Greenberg, The nonamer UUAUUUAUU is the key AU-rich sequence motif that mediates mRNA degradation, Mol. Cell. Biol. 15 (1992) 2219-2230.
36. [36] C.A. Lagnado, C.Y. Brown, G.J. Goodall, AUUUA is not sufficient to promote poly(A) tail shortening and degradation of an mRNA: The functional sequence within AU-rich elements may be UUAUUUA(U/A)(U/ A). Mol. Cell. Biol. 14 (1994) 7984-7995.
37. [37] D.S. Salomon, J.A, Zwiebel, M. Bono, L. Losonczy, P. Fehnel. W.R. Kidwell, Prescence of transforming growth factors in human breast cancer cells. Cancer Res. 44 (1984) 4069-4077.
38. [38] J.M. Connally, D.P. Rose, Secretion of epidermal growth factor and related pepfides by the DU 145 human prostate cancer cell line, Prostate 15 (1989) 177-186.
39. [39] B.W. Ennis, E.M. Valverius, S.E. Bates, M.E. Lippman, F. Bellot, R. Kris, J. Schlessinger, H. Masui, A. Goldenberg, J. Mendelsohn, Antiepidermal growth factor receptor antibodies inhibit the autocrine-stimulated growth of MDA-468 human breast cancer cells, Mol. Endocrinol. 3 (1989) 1830-1838.
40. [40] K.L. Thompson, M.R. Rosner, Regulation of epidermal growth factor receptor gene expression by retinoic acid and epidermal growth factor, J. Biol. Chem. 264 (1989) 3230-3234.
41. [41] R.J. Davis, M.P. Czech. Tumor-promoting phorbol esters cause the phosphorylation of epidermal growth factor receptors in normal human fibroblasts at threonine-654, Proc. Natl. Acad. Sci. USA 82 (1985) 1974-1978.
42. [42] P. Chomczyriski, N. Sacchi, Single-step method of RNA isolation by guanidinium thiocyanate phenol chloroform extraction, Anal. Biochem. 162 (1987) 156-159.
43. [43] J.A. Fernandez-Pol. P.D. Hamilton, D.J. Klos, Transcriplional regulation of proto-oncogene expression by epidermal growth factor, transforming growth factor β1, and tri-iodothyronine in MDA-468 cells, J. Biol. Chem. 264 (1989) 4151-4156.
44. [44] A.J. Clark, S. Ishii, N. Richert, G.T. Merlino, I. Pastan, Epidermal growth factor regulates the expression of its own receptor, Proc. Natl. Acad. Sci. USA 82 (1985) 8374-8378.
45. [45] P.J. Leedman, A.R. Stein, W.W. Chin, Regulated specific protein binding to a conserved region of the thyrotropin β-subunit mRNA 3′-untranslated region, Mol. Endocrinol. 9 (1995) 375-387.
46. [46] P.J. Leedman, A.R. Stein, W.W. Chin, J.T. Rogers. Thyroid hormone modulates the interaction between the iron regulatory proteins and the ferritin mRNA iron-responsive element. J. Biol. Chem, 271 (1996) 12017-12023.
47. [47] Y. Jinno, G.T. Merlino, I. Pastan, A novel effect of EGF on mRNA stability. Nucleic Acids Res. 16 (1988) 4957-4966.
48. [48] P. Kesavan, P. Das, J. Kern, M. Das, Regulation of stability and synthesis of EGF-receptor mRNAs encoding for intact and truncated receptor forms, Oncogene 5 (1990) 483-488.
49. [49] P. Kesavan, S. Mukhopadhayay, S. Murphy, M. Rengaraju, M.A. Lazar, M. Das, Thyroid hormone decreases the expression of epidermal growth factor receptor, J. Biol. Chem. 266 (1991) 10282-10286.
50. [50] H.S. Earp. K.S. Austin, J. Blaisdall, R.A. Rubin, K.G. Nelson, L.W. Lee, J.W. Grisham, Epidermal growth factor (EGF) stimulates EGF receptor synthesis, J. Biol. Chem. 261 (1986) 4777-4780.
51. [51] J.E. Kudlow, C.-Y.M. Cheung, J.D. Bjorge, Epidermal growth factor stimulates the synthesis of its own receptor in a human breast cancer cell line, J. Biol. Chem. 261 (1986) 4134-4138.
52. [52] Y. Satoh, M. Oomae, Y. Hoshikawa, M. Izawa, T. Sairenji, S. Ichii, The stability of truncated epidermal growth factor receptor mRNA is higher than that of the full-length receptor mRNA in rat hepatoma cells, Endocrine J. 44 (1997) 403-408.
53. [53] J.S. Malter, Identification of an AUUUA-speafic mRNA binding protein. Science 246 (1989) 664-666.
54. [54] P.R. Bohjanen, B. Petryniak, C.H. June, C.B. Thompson, T. Lindsten, An inducible cytoplasmic factor (AU-B) binds selectively to AUUUA multimers in the 3′ untranslated region of lymphokine mRNA. Mol. Cell. Biol. 11 (1991) 3288-3295.
55. [55] A.L. Harris, S. Nicholson, R. Samsbury, C. Wright, J. Farndon, Epidermal growth factor receptor and other oncogenes as prognostic markers. Natl. Cancer Institute Monograph. 11 (1992) 181-187.